Preserving Patient Access to Long-Term Care Pharmacies Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (15)
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Medicare/Medicaid
S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Mainstreet Pharmacy Access Act/the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on "Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program"; Comments to CMS on "Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)" Comments to CMS on "Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on "RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]"; Comments to CMS on "RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule "Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program"; Implementation of "reasonable and relevant" contract terms in the Medicare Part D Program; Comments to CMS on "Re: Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges [CMS-0062-P]"; Comments to CMS on "Re: Medicare GLP-1 Bridge Program - Improper Restriction of the $5.00 LTC Dispensing Fee to Nursing Facility and ICF/IID Residents; Conflict with 42 C.F.R. 423.120, Chapter 5, Section 20.7 of the Medicare Prescription Drug Benefit Manual, and CMSs December 15, 2021 Guidance on LTC Pharmacy Access"; Comments to CMS on "Re: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program [CMS-4215-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2027 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings [CMS-1848-P]"; S. 5496, Health CARE Act of 2026; S. 5586, Ensuring Accurate Payments to Specialty Pharmacies Act
Client expense: $370,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Health Issues
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Medicare/Medicaid
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Health Issues
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Client expense: $400,000 · Firm income: Not reported
| Republican |
| WV |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Health Issues
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Pharmacy
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
Policies and regulations related to CMS Proposed Rule; long-term care pharmacy definition; telehealth services related to Medicare; improving prior authorization process for seniors; H.R.1, One Big Beautiful Bill Act (P.L.119-21), Medicare Advantage issues; S.1002, No UPCODE Act; S.1816, Improving Seniors Timely Access to Care Act of 2025; H.R.4317, PBM Reform Act of 2025; H.R.5031/S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
H.R.1151, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; S.756, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; H.R.1812, Care Across Generations Act, to establish grants for long-term care facilities to co-locate or partner with childcare centers for intergenerational activities; H.R.1177, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.492, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.473, Social Engagement and Network Initiatives for Older Relief (SENIOR) Act, to promote senior socialization and combat isolation; H.R.2036, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.925, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.852, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2036, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2572, Start Applying Labor Transparency (SALT) Act, to increase transparency by requiring unions to register salts with the Department of Labor (DOL); H.R.3000, Caring for Seniors Act, to increase affordability of assisted living and invest in workforce development programs; H.R.1, One Big Beautiful Bill Act, to establish tax-savings programs to help seniors afford long-term care and to promote workforce development programs; H.R.138, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.1565, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.2762, Supporting Our Seniors Act, to establish a National Advisory Commission on long-term care services for seniors and individuals in need of support for activities of daily living; S.2120, Older Americans Act Reauthorization Act, to reauthorize the Older Americans Act and support programs to address social isolation and loneliness; H.R.5031, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; S.2699, Geriatrics Workforce Improvement Act, to reauthorize the Geriatrics Workforce Enhancement Program and Geriatrics Academic Career Awards; H.R.4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act, to promote comprehensive immigration reform to help support the foreign-born workforce needed across long-term care and other sectors; H.R.6231, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3265, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; H.R.5494, Essential Workers for Economic Advancement Act, to create a new H-2C nonimmigrant visa program for positions have gone unfilled in essential industries, such as health care and long-term care; H.R. 664421st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; S. 2651, 21st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; H.R. 5408, Faster Labor Contracts Actto promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector; S. 844, Faster Labor Contracts Act, to promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector; H.R. 1689, TPS Extension Act, to designate Haiti for temporary protected status through April 2029; S. 4386, ADVICE Act, to allow states and apprenticeship sponsors to collect and analyze key data on wages, retention, and completion rates; S. 4409, START Act, to accelerate the registration process for new apprenticeship programs; H. Res. 1299, 21st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; H.R. 8662, Assisted Living Affordability, Choice, Community, Empowerment, Savings and Support Act (ACCESS Act), to address concerns that would reduce access to senior housing and impose federal regulatory oversight; S. 4479, Assisted Living Affordability, Choice, Community, Empowerment, Savings and Support Act (ACCESS Act), to address concerns that would reduce access to senior housing and impose federal regulatory oversight; S. 2120, Older Americans Act Reauthorization Act, to reauthorize key senior legislation, including a new White House Conference on Aging, multigenerational engagement activities, and initiatives addressing social isolation.
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2026 · third_quarter · Medicare/Medicaid
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
S. 3159 / H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act (all sections of full text)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R.1151, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; S.756, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; H.R.1812, Care Across Generations Act, to establish grants for long-term care facilities to co-locate or partner with childcare centers for intergenerational activities; H.R.1177, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.492, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.473, Social Engagement and Network Initiatives for Older Relief (SENIOR) Act, to promote senior socialization and combat isolation; H.R.2036, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.925, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.852, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2036, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2572, Start Applying Labor Transparency (SALT) Act, to increase transparency by requiring unions to register salts with the Department of Labor (DOL); H.R.3000, Caring for Seniors Act, to increase affordability of assisted living and invest in workforce development programs; H.R.1, One Big Beautiful Bill Act, to establish tax-savings programs to help seniors afford long-term care and to promote workforce development programs; H.R.138, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.1565, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.2762, Supporting Our Seniors Act, to establish a National Advisory Commission on long-term care services for seniors and individuals in need of support for activities of daily living; S.2120, Older Americans Act Reauthorization Act, to reauthorize the Older Americans Act and support programs to address social isolation and loneliness; H.R.5031, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; S.2699, Geriatrics Workforce Improvement Act, to reauthorize the Geriatrics Workforce Enhancement Program and Geriatrics Academic Career Awards; H.R.4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act, to promote comprehensive immigration reform to help support the foreign-born workforce needed across long-term care and other sectors; H.R.6231, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3265, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; H.R.5494, Essential Workers for Economic Advancement Act, to create a new H-2C nonimmigrant visa program for positions have gone unfilled in essential industries, such as health care and long-term care; H.R. 664421st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; S. 2651, 21st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; H.R. 5408, Faster Labor Contracts Actto promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector; S. 844, Faster Labor Contracts Act, to promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector; H.R. 1689, TPS Extension Act, to designate Haiti for temporary protected status through April 2029; S. 4386, ADVICE Act, to allow states and apprenticeship sponsors to collect and analyze key data on wages, retention, and completion rates; S. 4409, START Act, to accelerate the registration process for new apprenticeship programs; H. Res. 1299, 21st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; H.R. 8662, Assisted Living Affordability, Choice, Community, Empowerment, Savings and Support Act (ACCESS Act), to address concerns that would reduce access to senior housing and impose federal regulatory oversight; S. 4479, Assisted Living Affordability, Choice, Community, Empowerment, Savings and Support Act (ACCESS Act), to address concerns that would reduce access to senior housing and impose federal regulatory oversight.
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2026 · second_quarter · Health Issues
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Pharmacy
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Policies and regulations related to CMS Proposed Rule; long-term care pharmacy definition; telehealth services related to Medicare; improving prior authorization process for seniors; H.R.1, One Big Beautiful Bill Act (P.L.119-21), Medicare Advantage issues; S.1002, No UPCODE Act; S.1816, Improving Seniors Timely Access to Care Act of 2025; H.R.4317, PBM Reform Act of 2025; H.R.5031/S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Mainstreet Pharmacy Access Act/the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on "Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program"; Comments to CMS on "Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)" Comments to CMS on "Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on "RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]"; Comments to CMS on "RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule "Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program"; Implementation of "reasonable and relevant" contract terms in the Medicare Part D Program; Comments to CMS on "Re: Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges [CMS-0062-P]"; Comments to CMS on "Re: Medicare GLP-1 Bridge Program - Improper Restriction of the $5.00 LTC Dispensing Fee to Nursing Facility and ICF/IID Residents; Conflict with 42 C.F.R. 423.120, Chapter 5, Section 20.7 of the Medicare Prescription Drug Benefit Manual, and CMSs December 15, 2021 Guidance on LTC Pharmacy Access";
Client expense: $270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · first_quarter · Medicare/Medicaid
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.1151, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; S.756, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; H.R.1812, Care Across Generations Act, to establish grants for long-term care facilities to co-locate or partner with childcare centers for intergenerational activities; H.R.1177, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.492, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.473, Social Engagement and Network Initiatives for Older Relief (SENIOR) Act, to promote senior socialization and combat isolation; H.R.2036, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.925, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.852, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2036, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2572, Start Applying Labor Transparency (SALT) Act, to increase transparency by requiring unions to register salts with the Department of Labor (DOL); H.R.3000, Caring for Seniors Act, to increase affordability of assisted living and invest in workforce development programs; H.R.1, One Big Beautiful Bill Act, to establish tax-savings programs to help seniors afford long-term care and to promote workforce development programs; H.R.138, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.1565, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.2762, Supporting Our Seniors Act, to establish a National Advisory Commission on long-term care services for seniors and individuals in need of support for activities of daily living; S.2120, Older Americans Act Reauthorization Act, to reauthorize the Older Americans Act and support programs to address social isolation and loneliness; H.R.5031, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; S.2699, Geriatrics Workforce Improvement Act, to reauthorize the Geriatrics Workforce Enhancement Program and Geriatrics Academic Career Awards; H.R.4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act, to promote comprehensive immigration reform to help support the foreign-born workforce needed across long-term care and other sectors; H.R.6231, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3265, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; H.R.5494, Essential Workers for Economic Advancement Act, to create a new H-2C nonimmigrant visa program for positions have gone unfilled in essential industries, such as health care and long-term care; H.R. 664421st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; S. 2651, 21st Century ROAD to Housing Act, to clarify provisions that could threaten the viability of existing seniors housing units; H.R. 5408, Faster Labor Contracts Actto promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector; S. 844, Faster Labor Contracts Act, to promote voluntary agreements, worker choice, and free enterprise, and prevent mandatory arbitration in the private sector.
Client expense: $75,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2026 · first_quarter · Medicare/Medicaid
S. 3159 / H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act (all sections of full text)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on "Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program"; Comments to CMS on "Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)" Comments to CMS on "Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on "RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]"; Comments to CMS on "RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule "Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program"; Implementation of "reasonable and relevant" contract terms in the Medicare Part D Program;
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · first_quarter · Health Issues
- H.R. 5031 / S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: $75,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Client expense: $1,320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · first_quarter · Health Issues
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Pharmacy
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Medicare/Medicaid
Policies and regulations related to CMS Proposed Rule; long-term care pharmacy definition; telehealth services related to Medicare; improving prior authorization process for seniors; H.R.1, One Big Beautiful Bill Act (P.L.119-21), Medicare Advantage issues; S.1002, No UPCODE Act; S.1816, Improving Seniors Timely Access to Care Act of 2025; H.R.4317, PBM Reform Act of 2025; H.R.5031/S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), home infusion HR 2172/S 1058, home health, home care, workforce development
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2026 · first_quarter · Medicare/Medicaid
Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), home infusion HR 2172/S 1058, home health, home care, workforce development
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · fourth_quarter · Medicare/Medicaid
Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), Medicare payment rules including hospice, home health and physician fee schedule (HR 5142 included), home infusion fix, Medicaid regulations, workforce development
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · fourth_quarter · Medicare/Medicaid
Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), Medicare payment rules including hospice, home health and physician fee schedule (HR 5142 included), home infusion fix, Medicaid regulations, workforce development
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · fourth_quarter · Medicare/Medicaid
S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on "Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program"; Comments to CMS on "Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)" Comments to CMS on "Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on "RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]"; Comments to CMS on "RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs;
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · fourth_quarter · Health Issues
- H.R. 1812 - Care Across Generations Act - S. 2762 - Supporting Our Seniors Act - H.R. 5031 / S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: $75,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1151, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; S.756, Freedom To Invest in Tomorrow's Workforce Act, to expand eligible uses of education savings accounts for career development; H.R.1812, Care Across Generations Act, to establish grants for long-term care facilities to co-locate or partner with childcare centers for intergenerational activities; H.R.1177, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.492, Improve and Enhance the Work Opportunity Tax Credit Act, to update the WOTC, increase the credit percentages and add additional credits for employers; S.473, Social Engagement and Network Initiatives for Older Relief (SENIOR) Act, to promote senior socialization and combat isolation; H.R.2036, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.925, Credit for Caring Act, to establish a tax credit for family caregivers of up to $5,000 to help offset long-term care expenses; S.852, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2036, Protecting the Right to Organize (PRO) Act, to prevent legislation that would exacerbate workforce challenges among senior living providers; H.R.2572, Start Applying Labor Transparency (SALT) Act, to increase transparency by requiring unions to register salts with the Department of Labor (DOL); H.R.3000, Caring for Seniors Act, to increase affordability of assisted living and invest in workforce development programs; H.R.1, One Big Beautiful Bill Act, to establish tax-savings programs to help seniors afford long-term care and to promote workforce development programs; H.R.138, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.1565, Lowering Costs for Caregivers Act, to allow health savings accounts and flexible spending accounts to be used by adult children on medical expenses for their parents; S.2762, Supporting Our Seniors Act, to establish a National Advisory Commission on long-term care services for seniors and individuals in need of support for activities of daily living; S.2120, Older Americans Act Reauthorization Act, to reauthorize the Older Americans Act and support programs to address social isolation and loneliness; H.R.5031, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; S.2699, Geriatrics Workforce Improvement Act, to reauthorize the Geriatrics Workforce Enhancement Program and Geriatrics Academic Career Awards; H.R.4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act, to promote comprehensive immigration reform to help support the foreign-born workforce needed across long-term care and other sectors; H.R.6231, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3265, Improve and Enhance the Work Opportunity Tax Credit Act, to extend and modernize the Work Opportunity Tax Credit to address workforce shortages; S.3159, Preserving Patient Access to Long-Term Care Pharmacies Act, to establish a temporary fee for LTC pharmacies to mitigate impacts of the Medicare Part D drug negotiation program; H.R.5494, Essential Workers for Economic Advancement Act, to create a new H-2C nonimmigrant visa program for positions have gone unfilled in essential industries, such as health care and long-term care.
Client expense: $45,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2025 · fourth_quarter · Medicare/Medicaid
S. 3159 / H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act (all sections of full text)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
S. 3159 / H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act (all sections of full text)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry and guidance on H.R. 5031/ S.3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · fourth_quarter · Medicare/Medicaid
S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation H.R. 10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers H.R. 5378 (118th Congress), Lower Cost, More Transparency Act H.R. 4317, PBM Reform Act of 2025 legislation on PBM reform in Medicare and pharmacy access standards S. 3159/H.R. 5031 Preserving Patient Access to Long Term Care Pharmacies Act provision designed to ensure continued access to essential medications and pharmacy services for seniors in long- term care facilities by establishing a temporary supply fee for pharmacies. H.R. 9096 Pharmacists Fight Back Act legislation to establish pharmacy payment, transparency requirements and reimbursement by pharmacy benefits managers in federal programs S.3345 - PBM Price Transparency and Accountability Act -provisions reforming PBM practices in Medicare in Medicaid including delinking, a ban on Medicaid spread pricing, transparency and audit rights H.R. 6703, the Lower Health Care Premiums for All Americans Act -provisions addressing PBM practices in Medicare and Medicaid
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · fourth_quarter · Health Issues
Issues related to pharmacy-related Medicare payments; Issues related to H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to pharmacy-related Medicare payments; Issues related to H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE